ARCHIVES

Hammer Gives $100,000 to Expand Rosenberg’s T-Cell Growth Factor Clinical Studies

This article is from The Cancer Letter archive.

Vol. 11 No. 09 | March 1, 1985

Download PDF Visit The Full Archive

Related Articles

Shubik Subcommittee Fails To Agree On Draft Document

February 13, 1976

FDA unlikely to pull Iressa from market. Iressa a case study in how not to develop a drug, ODAC member says.

April 1, 2005

Scientific Community Rallies To Support DeVita; Immediate Suspension Of Straus’ Grant Considered

June 12, 1981

Early HER2 Positive Patients At Higher Risk of Recurrence

January 30, 2009

Chemo Can Harm Liver, Affect Surgical Outcomes

May 26, 2006

Includes May issue of Business & Regulatory Report.

May 31, 2002